BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Science 37 Reports Third Quarter 2023 Financial Results

  Science 37 Holdings, Inc., the industry-leading Metasite™, reported its financial results for the quarter ended September 30, 2023.

  November 7, 2023

   · 

  18 min read
• Business

  Mallinckrodt plc (in Examinership) Reports Third Quarter 2023 Financial Results

  Mallinckrodt plc, a global specialty pharmaceutical company, reported its financial results for the third quarter ended September 29, 2023.

  November 7, 2023

   · 

  40 min read
• Business

  BrainStorm to Announce Third Quarter 2023 Financial Results and Provide a Corporate Update

  BrainStorm Cell Therapeutics Inc. announced that it will hold a conference call on Tuesday, November 14th at 8:30 a.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2023 and provide a corporate update.

  November 7, 2023

   · 

  4 min read
• Business

  IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

  IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  29 min read
• Business

  Amneal Reports Third Quarter 2023 Financial Results

  Amneal Pharmaceuticals, Inc. announced its results for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  30 min read
• BioMed X Launches a New Call for Application in Autoimmune Disease Research

  BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology.

  November 7, 2023

   · 

  2 min read
• Business

  Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023

  Affimed N.V. announced that it will release third quarter 2023 results and corporate update on Tuesday, November 14, 2023.

  November 7, 2023

   · 

  1 min read
• Business

  SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023 Record results on growth acceleration, significant improvement in operating loss and cash burn

  SOPHiA GENETICS SA, a cloud-native software company and a leader in data-driven medicine, reported financial results for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  22 min read
• Business

  Zimmer Biomet Announces Third Quarter 2023 Financial Results

  Zimmer Biomet Holdings, Inc. reported financial results for the quarter ended September 30, 2023.

  November 7, 2023

   · 

  16 min read
• Business

  Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide Corporate Update

  Immunic, Inc. announced that the company will release its financial results for the third quarter ended September 30, 2023, including a corporate update, on Tuesday, November 14, 2023, before the opening of the U.S.

  November 7, 2023

   · 

  5 min read